Entero Healthcare soars on acquiring majority stake in Anand Chemiceutics
The business of Anand Chemiceutics is in line with the business of the Company i.e. wholesale distribution of medical devices and other allied products
Entero Healthcare Solutions is currently trading at Rs. 1176.95, up by 40.20 points or 3.54% from its previous closing of Rs. 1136.75 on the BSE.
The scrip opened at Rs. 1165.05 and has touched a high and low of Rs. 1176.95 and Rs. 1142.15 respectively. So far 1377 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1509.90 on 26-May-2025 and a 52 week low of Rs. 944.00 on 29-Dec-2025.
Last one week high and low of the scrip stood at Rs. 1190.25 and Rs. 1102.70 respectively. The current market cap of the company is Rs. 5121.02 crore.
The promoters holding in the company stood at 52.42%, while Institutions and Non-Institutions held 21.56% and 26.02% respectively.
Entero Healthcare Solutions has completed acquisition of majority equity stake (51.51%) in Anand Chemiceutics. The business of Anand Chemiceutics is in line with the business of the Company i.e. wholesale distribution of medical devices and other allied products.
Entero Healthcare Solutions is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.

